Here's how you can reach us...
  • Tel:
  • Email:

Real-Time Stability Analysis for Nucleic Acid Drugs

Inquiry

CD Formulation specializes in providing real-time stability analysis services for nucleic acid drugs. Our mission is to ensure the efficacy and safety of nucleic acid drugs during storage and usage through advanced analytical techniques and a professional scientific team. Our services help clients gain in-depth insights into drug degradation pathways and stability, supporting drug development and quality control.

About Real-Time Stability Analysis for Nucleic Acid Drugs

Real-time stability analysis of nucleic acid drugs is vital for maintaining their quality and effectiveness throughout their shelf life. This involves assessing how these drugs react and remain stable under different environmental conditions, providing data crucial for predicting their long-term performance. By evaluating test results from various batches, manufacturers can refine production and storage practices, ensuring consistent drug efficacy and minimizing quality-related risks.

Design of Real-Time Stability Analysis

Items Descriptions
Identifying Key Parameters Determine essential factors impacting nucleic acid drug stability, like heat, moisture, and illumination, and implement targeted monitoring plans.
Selecting Appropriate Analytical Technologies Employ analytical methods aligned with nucleic acid properties, such as UV-Vis spectrometry, fluorescence analysis, and mass spectrometry, to conduct ongoing stability monitoring.
Developing Effective Testing Conditions Design stability testing conditions by simulating as many storage conditions as possible through high-temperature or high-humidity environments to predict the stable performance of nucleic acid drugs.
Establishing Comparison Benchmarks Create benchmarks for each test condition to ensure clear distinction between changes caused by degradation.

Explore Our Real-Time Stability Analysis Services for Nucleic Acid Drugs

In the real-time stability analysis of nucleic acid drugs, CD Formulation provides precise stability assessment for pharmaceutical companies through comprehensive component and physicochemical property analysis, efficiency and bioactivity evaluation, and environmental response testing and trend analysis. Our professional team customizes testing plans for each drug to ensure its safety and effectiveness throughout its shelf life and supports long-term quality assurance with scientific data trend analysis.

Component and Physicochemical Property Analysis

Conducting real-time stability tests for nucleic acid drugs first requires a detailed analysis of their components. The aim is to ensure chemical composition consistency over the entire shelf life, including long-term monitoring of active ingredients and additives. Additionally, this step focuses on evaluating physical properties such as solubility, particle size, and crystal structure, as well as easily observable changes (e.g., color, appearance, and odor). These physical and chemical properties must always meet the standards approved at the time of drug approval to ensure the drug remains effective and safe when used.

Bioactivity Evaluation

In stability assessment, the drug's efficacy and bioactivity are critical indicators that cannot be overlooked. Real-time testing typically uses in vitro systems to evaluate the drug's biological effects and verify its ability to maintain efficacy after long-term storage. Furthermore, bioactivity evaluation involves analyzing potential degradation products to determine their impact on drug efficacy. This process aids in identifying optimal storage conditions to ensure the efficacy of packaging and storage guidelines.

Environmental Response Testing

Another core part of stability testing for nucleic acid drugs is testing their stability through reactions under different environmental conditions. This involves experiments under changing temperature, humidity, light, and vibration conditions. These tests should be conducted regularly across different batches of pharmaceuticals to collect data and measure the effects of long-term storage. By analyzing these data trends and comparing results between batches, we ensure consistency and accuracy to draw data-based conclusions. Through comprehensive trend analysis, researchers can predict the long-term stability of the drug and subsequently optimize formulations or manufacturing processes to enhance product quality.

Workflow of Real-Time Stability Analysis Services for Nucleic Acid Drugs

Fig.1 Diagram illustrating the process for analyzing the stability of nucleic acid drugs in real-time.Fig.1 Flow chart of real-time stability analysis for nucleic acid drugs. (CD Formulation)

  • Sample Preparation

Firstly, mix nucleic acid drugs with reagent buffers to ensure the drug retains its activity under appropriate conditions.

  • Temperature Control

Use temperature control equipment to place samples under designed temperatures to simulate actual storage or use environments, thereby monitoring their stability.

  • Time Monitoring

Regularly collect samples and perform analyses at preset time points to observe stability changes of nucleic acid drugs at different time nodes.

  • Data Collection

Use specific analytical instruments, such as spectrometers or mass spectrometers, to detect samples and obtain degradation or change data.

  • Result Analysis

Input the collected data into computational models to evaluate the stability of nucleic acid drugs and predict their effective usage period.

Our Technology Platforms

Our real-time stability analysis technology for nucleic acid drugs involves complex biomolecular detection and monitoring methods, with the main technical platforms including the following components.

Our Advantages of Real-Time Stability Analysis Services

  • Real-time stability analysis allows for precise monitoring of nucleic acid drug degradation and change under various environmental conditions.
  • Real-time data collection and analysis provide a rapid response to timely adjustments in drug storage and usage strategies.
  • Early detection of drug instability can reduce unnecessary waste and associated costs, improving economic benefits.
  • Real-time analysis enhances data reliability and consistency, providing strong support for the safety and effectiveness of the final product.

Publication Data

Technology: Real-time stability analysis utilizing the DSC technology platform

Journal: Journal of pharmaceutical sciences

IF: 3.7

Published: 2021

Results:

This document outlines a two-phase approach for evaluating recombinant protein antigenic variants across various formulations, aiming to swiftly pinpoint stable aluminum-adjuvanted multidose vaccine options. In a proof-of-concept study, different sequence variants of the NRRV P[8] protein from Komagataella phaffii were assessed based on factors like primary structure, modifications after translation, antibody interaction, structural stability, solubility, and compatibility with preservatives. For the aluminum-adjuvanted P[8] variant, the rapidly obtained screening results aligned well with the stability profile over 12 weeks at varying temperatures. These observations were further validated using another NRRV antigen variant, P[4].

Fig.2 Study encompassing both accelerated and realtime stability assessments.Fig.2 Accelerated and real-time stability study. (Sawant N, et al., 2021)

CD Formulation offers transparent and uninterrupted feedback for your service needs. Please feel free to contact us at any time, our technical team can closely collaborate with you to successfully and promptly conduct stability studies to evaluate shelf life.

References

  1. Sawant N, Kaur K, Holland D A, et al. Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens. J Pharm Sci. 2021, 110(3): 1042-1053.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services

At CD Formulation, we understand the unique challenges and opportunities associated with nucleic acid formulation development. Our team of experts is dedicated to providing tailored solutions...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.   Privacy Policy  Cookie Policy